Molecular biology reportsFlavanonesAutophagyAnimalsTOR Serine-Threonine KinasesRats
Naringin mitigates liver damage in a tissue-engineered liver of metabolic dysfunction-associated steatotic liver disease model by promoting autophagy via the mTOR-ULK1 pathway.
Jihui Jia, Yizhi Zhang, Jing Lin, Zhongping Duan, Yu Chen, Xiaohui Zhang
Published: 202510.1007/s11033-025-11102-0
Abstract
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic liver disease with complex pathogenesis. Autophagy is involved in the occurrence and development of MASLD. Naringin is a flavonoid compound with anti-inflammato…
Preview only. Read the full abstract at the source